{"id":273705,"date":"2025-10-03T05:03:13","date_gmt":"2025-10-03T05:03:13","guid":{"rendered":"https:\/\/www.europesays.com\/us\/273705\/"},"modified":"2025-10-03T05:03:13","modified_gmt":"2025-10-03T05:03:13","slug":"ozempic-cleared-for-use-in-india-to-know-benefits-side-effects-of-ozempic-inshorts-inshorts","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/us\/273705\/","title":{"rendered":"Ozempic cleared for use in India | To know benefits & side-effects of Ozempic | Inshorts – Inshorts"},"content":{"rendered":"
    \n
  1. Ozempic cleared for use in India | To know benefits & side-effects of Ozempic | Inshorts<\/a>  Inshorts<\/li>\n
  2. Ozempic approved for use in India: All you need to know about its benefits, risks and price<\/a>  Hindustan Times<\/li>\n
  3. Ozempic Coming Soon To India: 14 Facts About The Diabetes, Weight Loss Drug<\/a>  NDTV<\/li>\n
  4. Novo Nordisk’s blockbuster drug Ozempic’s India launch is imminent, so are its generic versions<\/a>  Fortune India<\/li>\n
  5. Ozempic Gets India Nod: What To Know Before Trying Hollywood’s Favourite Weight-Loss Drug | Explainers News<\/a>  News18<\/li>\n<\/ol>\n","protected":false},"excerpt":{"rendered":"Ozempic cleared for use in India | To know benefits & side-effects of Ozempic | Inshorts  Inshorts Ozempic approved…\n","protected":false},"author":3,"featured_media":273706,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[34],"tags":[104,30236,3240,106,17407,210,82079,1567,105,728,1060,1571,50,82076,427,67,132,68,82078,82077,82075],"class_list":{"0":"post-273705","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-medication","8":"tag-breaking-news","9":"tag-cleared","10":"tag-current-affairs","11":"tag-current-news","12":"tag-daily-news","13":"tag-health","14":"tag-health___fitness","15":"tag-india","16":"tag-latest-news","17":"tag-local-news","18":"tag-medication","19":"tag-national","20":"tag-news","21":"tag-news-online","22":"tag-ozempic","23":"tag-united-states","24":"tag-unitedstates","25":"tag-us","26":"tag-82078","27":"tag-82077","28":"tag-82075"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@us\/115308488580162939","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts\/273705","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/comments?post=273705"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts\/273705\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/media\/273706"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/media?parent=273705"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/categories?post=273705"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/tags?post=273705"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}